Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Total Non-Current Liabilities (2018 - 2025)

Orthopediatrics has reported Total Non-Current Liabilities over the past 8 years, most recently at $115.8 million for Q4 2025.

  • Quarterly results put Total Non-Current Liabilities at $115.8 million for Q4 2025, up 36.79% from a year ago — trailing twelve months through Dec 2025 was $115.8 million (up 36.79% YoY), and the annual figure for FY2025 was $115.8 million, up 36.79%.
  • Total Non-Current Liabilities for Q4 2025 was $115.8 million at Orthopediatrics, up from $110.9 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for KIDS hit a ceiling of $115.8 million in Q4 2025 and a floor of $10.2 million in Q3 2023.
  • Median Total Non-Current Liabilities over the past 5 years was $53.0 million (2021), compared with a mean of $53.2 million.
  • Biggest five-year swings in Total Non-Current Liabilities: tumbled 85.87% in 2023 and later surged 722.05% in 2024.
  • Orthopediatrics' Total Non-Current Liabilities stood at $49.2 million in 2021, then tumbled by 62.98% to $18.2 million in 2022, then increased by 10.14% to $20.1 million in 2023, then skyrocketed by 322.26% to $84.7 million in 2024, then skyrocketed by 36.79% to $115.8 million in 2025.
  • The last three reported values for Total Non-Current Liabilities were $115.8 million (Q4 2025), $110.9 million (Q3 2025), and $109.4 million (Q2 2025) per Business Quant data.